Optilume Device for Urethral Stricture and Benign Prostatic Hyperplasia
Customize your policy alerts
Sign up for blue cross blue shield - louisiana Policy MA-244 alerts
Get alerted when Policy MA-244 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage of the Optilume Urethral drug-coated balloon for recurrent bulbar urethral stricture and the Optilume BPH Catheter System for lower urinary tract symptoms secondary to benign prostatic hyperplasia when applicable benefits and medical-necessity criteria are met.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.